Evaluation and Management of Cerebral Vasospasm after Subarachnoid Hemorrhage

Alabdaly, Hani Mohammed and Alassaf, Othman Mohammad and Kabrah, Danah Kamal and Almadi, Khaled Bassam and Alhabib, Renda Ali and Alotaibi, Rakan M. and Almalki, Abdullah Salem and Alghamdi, Fahad Azib and Albalawi, Reema Abdullah H and Hakami, Laila Hamad and Alajmi, Moudhi Mohammed (2021) Evaluation and Management of Cerebral Vasospasm after Subarachnoid Hemorrhage. Journal of Pharmaceutical Research International, 33 (60B). pp. 494-500. ISSN 2456-9119

[thumbnail of 6676-Article Text-9095-1-10-20221006.pdf] Text
6676-Article Text-9095-1-10-20221006.pdf - Published Version

Download (288kB)

Abstract

Constriction of the large and medium-sized cerebral arteries following an aneurysmal subarachnoid haemorrhage (aSAH) is a well-known condition that primarily affects the anterior circulation supplied by the internal carotid arteries. SAH is a rare but potentially fatal type of stroke. Across the literature, authors have defined vasospasm using terms such as "symptomatic vasospasm," "delayed cerebral ischemia" (DCI), "transcranial Doppler vasospasm," and "angiographic vasospasm." Because posthemorrhagic vasospasm causes significant neurologic morbidity and death, there has been a great deal of interest and research into its physiologic basis and developing effective preventative and treatment strategies. The triple-H therapy hemodynamic augmentation technique, which includes hypertension, hemodilution, and hypervolemia, has been an important part of the treatment. In this article, we'll look at cerebral vasospasm following subarachnoid haemorrhage, including its causes, epidemiology, evaluation, and, most importantly, management.

Item Type: Article
Subjects: STM One > Medical Science
Depositing User: Unnamed user with email support@stmone.org
Date Deposited: 02 Mar 2023 08:50
Last Modified: 17 Jul 2024 09:42
URI: http://publications.openuniversitystm.com/id/eprint/146

Actions (login required)

View Item
View Item